Total Payments
$1,854
2024 Payments
$103.85
Companies
11
Transactions
28
Medicare Patients
1,755
Medicare Billing
$253,268
Payment Breakdown by Category
Travel$995.70 (53.7%)
Food & Beverage$858.69 (46.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $995.70 | 2 | 53.7% |
| Food and Beverage | $858.69 | 26 | 46.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $1,411 | 3 | $0 (2019) |
| Horizon Therapeutics plc | $127.19 | 13 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $120.15 | 1 | $0 (2018) |
| CALLIDITAS THERAPEUTICS US INC. | $54.32 | 3 | $0 (2024) |
| Amgen Inc. | $34.52 | 2 | $0 (2024) |
| Abbott Laboratories | $23.41 | 1 | $0 (2022) |
| NxStage Medical, Inc. | $23.13 | 1 | $0 (2018) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $20.28 | 1 | $0 (2020) |
| Renalytix AI, Inc. | $15.53 | 1 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $15.01 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $103.85 | 6 | CALLIDITAS THERAPEUTICS US INC. ($54.32) |
| 2023 | $142.72 | 14 | Horizon Therapeutics plc ($127.19) |
| 2022 | $23.41 | 1 | Abbott Laboratories ($23.41) |
| 2020 | $20.28 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($20.28) |
| 2019 | $1,421 | 4 | Fresenius USA Marketing, Inc. ($1,411) |
| 2018 | $143.28 | 2 | Otsuka America Pharmaceutical, Inc. ($120.15) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/14/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Nephrology | ||||||
| 07/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Nephrology | ||||||
| 04/03/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Nephrology | ||||||
| 01/31/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/30/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $3.97 | General |
| Category: KRYSTEXXA | ||||||
| 11/09/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: KRYSTEXXA | ||||||
| 10/19/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: KRYSTEXXA | ||||||
| 10/18/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: KRYSTEXXA | ||||||
| 10/11/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: KRYSTEXXA | ||||||
| 10/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: KRYSTEXXA | ||||||
| 10/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: KRYSTEXXA | ||||||
| 09/21/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: KRYSTEXXA | ||||||
| 09/18/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: KRYSTEXXA | ||||||
| 08/16/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: KRYSTEXXA | ||||||
| 07/19/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: KRYSTEXXA | ||||||
| 06/15/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: KRYSTEXXA | ||||||
| 05/22/2023 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/11/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: KRYSTEXXA | ||||||
| 08/15/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Heart Failure | ||||||
| 07/08/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/07/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.59 | General |
| Category: NEPHROLOGY | ||||||
| 01/18/2019 | Fresenius USA Marketing, Inc. | — | Travel and Lodging | Cash or cash equivalent | $765.87 | General |
| 01/18/2019 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $415.56 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 341 | 726 | $122,577 | $49,638 |
| 2022 | 6 | 451 | 996 | $183,940 | $69,825 |
| 2021 | 6 | 501 | 982 | $189,350 | $71,663 |
| 2020 | 9 | 462 | 780 | $477,538 | $62,142 |
Total Patients
1,755
Total Services
3,484
Medicare Billing
$253,268
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 131 | 384 | $54,528 | $23,264 | 42.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 93 | 98 | $26,460 | $9,478 | 35.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 47 | 118 | $16,992 | $6,472 | 38.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 69 | $14,145 | $6,322 | 44.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $5,586 | $1,869 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 24 | $3,384 | $1,504 | 44.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 19 | $1,482 | $728.84 | 49.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 172 | 519 | $70,290 | $28,565 | 40.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 157 | $30,820 | $12,454 | 40.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 96 | 98 | $25,285 | $10,251 | 40.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 61 | $22,359 | $9,356 | 41.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 63 | 137 | $32,012 | $7,749 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 24 | $3,174 | $1,452 | 45.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 200 | 497 | $64,610 | $28,021 | 43.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 51 | 163 | $30,970 | $13,203 | 42.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 107 | 110 | $26,950 | $11,640 | 43.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 60 | 62 | $22,010 | $9,698 | 44.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 72 | 137 | $42,470 | $7,887 | 18.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 13 | $2,340 | $1,214 | 51.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 116 | 285 | $248,448 | $23,628 | 9.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 97 | 225 | $34,100 | $12,878 | 37.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 66 | 66 | $19,822 | $7,257 | 36.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 81 | 82 | $74,292 | $6,708 | 9.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 37 | $51,075 | $5,977 | 11.7% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 23 | 43 | $13,330 | $2,534 | 19.0% |
About Dr. Sean Gaines, DO
Dr. Sean Gaines, DO is a Nephrology healthcare provider based in Solon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2013. The National Provider Identifier (NPI) number assigned to this provider is 1609217934.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Gaines, DO has received a total of $1,854 in payments from pharmaceutical and medical device companies, with $103.85 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Travel and Lodging" ($995.70).
As a Medicare-enrolled provider, Gaines has provided services to 1,755 Medicare beneficiaries, totaling 3,484 services with total Medicare billing of $253,268. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Solon, OH
- Active Since 07/15/2013
- Last Updated 08/13/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1609217934
Products in Payments
- KRYSTEXXA (Biological) $161.71
- JYNARQUE (Drug) $120.15
- TARPEYO (Drug) $54.32
- CARDIOMEMS (Device) $23.41
- System One (Device) $23.13
- LifeVest (Device) $20.28
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $15.53
- WAINUA (Drug) $15.01
- AURYXIA (Drug) $9.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.